TrialClinical rheumatology2007

Treatment with anti-TNF-alpha antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis.

Yasunori Kageyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.